Skip to main content

Table 1 Demographics and comorbidities of the 216 included patients, and comparison according to the consumption of anti-inflammatory drugs prior to admission

From: Impact of anti-inflammatory drug consumption in peritonsillar abscesses: a retrospective cohort study

  Total population No AID consumption AID consumption p-value
Demographics 216 89 (41.2 %) 127 (58.7 %)  
 Sex (male) 119 (55.1 %) 52 (58.4 %) 67 (52.8 %) 0.410
 Age (years) 32.2 (25.7–39.5) 31.3 (25.6–38.9) 32.8 (25.7–39.7) 0.670
Comorbidities
 BMI (kg/cm2) 23.6 (21.7–26.5) 25.1 (22.0–28.6) 23.4 (20.6–25.8) 0.091
 Diabetes 3 (1.4 %) 3 (3.4 %) 0 (0.0 %) 0.069
 Chronic respiratory disease 2 (0.9 %) 1 (1.1 %) 1 (0.8 %) 1.000
 Pharyngitis 24 (11.1 %) 13 (14.6 %) 11 (8.7 %) 0.171
 Peritonsillar suppuration 16 (7.4 %) 9 (10.1 %) 7 (5.5 %) 0.204
 Immunosuppression 5 (2.3 %) 1 (1.1 %) 4 (3.1 %) 0.651
 Hematological malignancy or solid tumor 2 (0.9 %) 0 (0 %) 2 (1.6 %) 0.513
 Tabaco consumption 63 (52.1 %) 30 (53.6 %) 33 (50.8 %) 0.758
  1. Data are presented as n (%) for dichotomic variables and median (IQR) for continuous variables. For the calculation of each percentage, the number of missing values was excluded from the denominator. The two groups were compared by non-parametric tests (chi-square test, Fisher exact test and Mann–Whitney U-test), as appropriate
  2. AID anti-inflammatory drug, BMI body mass index